Boeing's delivery surge represents the strongest operational performance in years, creating a powerful tailwind for the entire aerospace supply chain that could accelerate throughout 2024.
When Boeing's production accelerates, the benefits ripple through dozens of suppliers who manufacture everything from engines to advanced composites, potentially amplifying returns across the sector.
These aerospace suppliers are positioned at the perfect inflection point where increased orders meet improved demand forecasting, offering exposure to a sector emerging from its toughest period in decades.
Boeing's highest aircraft deliveries since 2018 signal a pivotal aerospace recovery. This surge in production creates a ripple effect through the entire supply chain, from engine makers to component manufacturers. We've identified companies positioned to benefit from increased orders and more reliable demand forecasts as Boeing's production lines accelerate.
This collection focuses on the broader aerospace ecosystem beyond just Boeing itself. These suppliers manufacture everything from aerostructures and composite materials to engine components and avionic systems. The theme captures the cyclical recovery in aerospace, directly tied to operational improvements from a market leader with a vast supplier network.
Each company was handpicked for their direct involvement in Boeing's supply chain and their potential to benefit from increased aircraft production. From primary aerostructure suppliers to advanced materials manufacturers, these stocks represent essential links in the aerospace value chain positioned for the current recovery tailwind.
Boeing's airplane deliveries have surged to a seven-year high, signaling a significant operational recovery. This rebound creates a potential tailwind for the entire aerospace supply chain, from engine makers to component manufacturers.
The basket's total market capitalisation is 415,702.20, with a few very large-cap constituents anchoring most of the weight. This concentration generally leads to more stable, market-correlated performance than small-cap‑heavy baskets.
BA: $183.65B
SPR: $4.64B
HWM: $87.76B
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+4
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitiv Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+1.65%
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 1.65 % zulegen.
11 von 14 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
